Pentasa (UK) is a specialized medication designed for the treatment of inflammatory bowel diseases, including ulcerative colitis and Crohn's disease. Its active ingredient, mesalazine, works by reducing inflammation in the lining of the intestines, providing relief from symptoms such as abdominal pain, diarrhea, and rectal bleeding. Pentasa is available in a 500MG tablet form, making it easy to administer and integrate into daily routines. This medication is particularly effective for maintaining remission in patients with mild to moderate ulcerative colitis. Always consult your healthcare provider to determine the appropriate dosage and usage for your specific condition.